Precursor Lymphoid Neoplasm — Trials

Precursor Lymphoid Neoplasm — Trials · CancerIndex

Clinical trials

Registered studies

2,154 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 567
Recruiting: 344
Ph III recruiting: 27
Growth YoY: −11.9%
Industry share: 13%
Top sponsor: City of Hope Medical Center
Termination share: 33.1%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (286)

clinicaltrialsPublishedShowing 151–200 of 256 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT06253637	Daratumumab in VHR T-ALL Treated According to the ALL National Treatment Program(DARATALL-VHR)	active not recruiting	Phase 2	31	Gruppo Italiano Malattie EMatologiche dell'AdultoOTHER	1	Mar 5, 2026	clinicaltrials
NCT06052813	A Study of BN104 in the Treatment of Acute Leukemia	active not recruiting	Phase 1 / Phase 2	66	Institut de Recherches Internationales Servier (I.R.I.S.)INDUSTRY	1